Marimed (MRMD) Gross Profit (2011 - 2026)

Marimed (MRMD) has reported Gross Profit for 16 consecutive years, with $16.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit rose 1.87% year-over-year to $16.2 million in Q2 2026; TTM through Jun 2026 was $58.4 million, a 3.45% decrease from a year earlier, with the FY2025 full-year figure at $57.9 million, down 7.56% from the prior year.
• Gross Profit was $16.2 million for Q2 2026 at Marimed, up from $15.3 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.3 million in Q4 2023 and troughed at $10.5 million in Q4 2025.
• A 5-year average of $15.7 million and a median of $16.2 million in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit increased 28.74% in 2022 and dropped 26.92% in 2024, its largest moves.
• Over 5 years, Gross Profit stood at $15.8 million in 2022, then climbed by 9.52% to $17.3 million in 2023, then declined by 26.92% to $12.7 million in 2024, then retreated by 17.02% to $10.5 million in 2025, then jumped by 54.49% to $16.2 million in 2026.
• The last three Gross Profit figures came in at $16.2 million (Q2 2026), $15.3 million (Q1 2026), and $10.5 million (Q4 2025), per Business Quant data.